Enitociclib

Enitociclib is an experimental drug that is being investigated for the treatment of cancer. It is an inhibitor of the kinase CDK9.
Wikipedia contributors, "Enitociclib", Wikipedia, revision 1370066422, retrieved 20 November 2026, source, CC BY-SA 4.0.